COA3

COA3 is a small, intrinsically disordered intrinsic protein of the inner mitochondrial membrane that functions as an early assembly factor for cytochrome c oxidase (complex IV), coupling synthesis of the mitochondrially encoded COX1 subunit to its incorporation into the holoenzyme (PMID:20876281, PMID:23362268, PMID:27791355). It assembles with newly synthesized COX1 and the assembly factor COX14 into an early intermediate and co-translationally stabilizes COX1, with loss of COA3 reducing the stability and steady-state level of nascent COX1 (PMID:23362268, PMID:25604084). COA3 and COX14 are mutually interdependent for stability—neither protein is detectable in cells lacking the other—and together they gate COX1 maturation before recruitment of the COX4 and COX5a subunits (PMID:25604084, PMID:28082314). In yeast, COA3/Cox25 acts with Cox14 and Coa1 to recruit the translational activator Mss51 into a latent, translation-resting state, thereby providing negative feedback on COX1 synthesis; the same intermediate is further stabilized in humans by CMC1, which controls turnover rather than the rate of COX1 synthesis (PMID:20876281, PMID:21068384, PMID:28082314). The factor is essential for complex IV assembly across species, and in humans compound heterozygous COA3 mutations cause isolated complex IV deficiency (PMID:22610097, PMID:25604084). Deficiency provokes ROS-mediated release of mitochondrial RNA and sterile inflammation, paralleling the COX14 phenotype (PMID:39134548).

1. 2010 High

   Established that COA3 is a core component of the earliest COX1-containing assembly intermediates and, with Cox14, governs a translational feedback loop that throttles COX1 synthesis via Mss51 sequestration.

   Evidence Genetic deletion, reciprocal Co-IP, sucrose gradient sedimentation and pulse-chase translation labeling in yeast

   PMID:20876281 PMID:21068384

   Open questions at the time

   • Whether the human ortholog reproduces the Mss51-based translational feedback was not addressed
   • Topology and biophysical basis of complex formation not resolved in these studies
2. 2012 High

   Showed the requirement for COA3 in complex IV assembly is conserved in a metazoan, with specificity for complex IV among OXPHOS complexes.

   Evidence Two independent Drosophila knockout alleles with enzymatic assays, BN-PAGE and transgenic rescue

   PMID:22610097

   Open questions at the time

   • Did not define the molecular interaction partners in flies
   • Did not distinguish translational from post-translational COX1 effects
3. 2013 High

   Demonstrated that the human protein co-translationally stabilizes nascent COX1 and bridges the mitochondrial translation machinery to COX structural subunits.

   Evidence siRNA knockdown, pulse-chase mitochondrial translation labeling, Co-IP and BN-PAGE in human cells

   PMID:23362268

   Open questions at the time

   • Did not resolve which translation-machinery components are directly contacted
   • Stoichiometry of the COX1-bound intermediate not defined
4. 2015 High

   Linked COA3 loss-of-function directly to human disease and established mutual stability dependence with COX14.

   Evidence Whole exome sequencing, patient fibroblast biochemistry, pulse-chase labeling and retroviral complementation rescue

   PMID:25604084

   Open questions at the time

   • Structural basis of the COA3-COX14 interdependence unresolved
   • Genotype-phenotype relationships across additional patients not established
5. 2017 High

   Refined the human intermediate by adding CMC1 and reframed COA3/COX14 function as regulating COX1 turnover rather than synthesis rate in human cells.

   Evidence TALEN knockout of CMC1 in HEK293T, Co-IP, BN-PAGE and pulse-chase labeling

   PMID:28082314

   Open questions at the time

   • Reconciliation of the human turnover model with the yeast translational-feedback model not fully resolved
   • Order of CMC1 vs COA3 recruitment to COX1 not defined
6. 2017 Medium

   Placed COA3 in functional coupling with a mitoribosomal component (MrpL35) that coordinates COX1 synthesis with assembly.

   Evidence Genetic epistasis, respiratory growth assays and Co-IP in yeast

   PMID:28931599

   Open questions at the time

   • COA3 involvement inferred from genetic interaction, not direct biochemical reconstitution
   • Direct COA3-mitoribosome contact not demonstrated
7. 2016 Medium

   Identified a COX1 synthesis pathway (Pet54) acting upstream of or in parallel to the COA3/COX14-Mss51 feedback loop, delimiting the regulatory scope of COA3.

   Evidence Genetic double-deletion analysis, pulse-chase labeling and RNA Co-IP in yeast

   PMID:26929411

   Open questions at the time

   • Mechanistic relationship between Pet54 and the COA3 complex not biochemically defined
   • Human relevance not tested
8. 2016 Medium

   Characterized the human protein as intrinsically disordered and conformationally flexible, providing a biophysical rationale for its multivalent assembly-factor role.

   Evidence Fluorescence spectroscopy, circular dichroism, analytical ultracentrifugation, light scattering and computational modeling

   PMID:27791355

   Open questions at the time

   • No mutagenesis linking disorder to assembly function
   • Conformation within the native membrane complex not determined
9. 2019 Low

   Reported a mitochondrial physical interaction between COA3 and EGFL9 associated with metabolic reprogramming.

   Evidence Co-IP, confocal co-localization, COX activity and metabolic flux assays

   PMID:31695034

   Open questions at the time

   • Single Co-IP without reciprocal validation or COA3 perturbation
   • Causal role of COA3 in the Warburg-like phenotype not tested
10. 2024 Medium

    Demonstrated in vivo consequences of COA3 deficiency, linking complex IV failure to ROS-driven mitochondrial RNA release and sterile inflammation.

    Evidence COA3Y72C knock-in mouse with comparative phenotyping against a COX14 mutant, complex IV activity assays and cytosolic RNA sensing analysis

    PMID:39134548

    Open questions at the time

    • COA3 phenotype described as milder/secondary to COX14, leaving COA3-specific contribution incompletely separated
    • Tissue specificity of the inflammatory response not fully mapped

• It remains unresolved how the yeast Mss51 translational-feedback model and the human turnover-based model are mechanistically reconciled, and what structural arrangement COA3 adopts within the COX1-COA3-COX14-CMC1 intermediate.
• No high-resolution structure of the early assembly intermediate
• Direct human equivalent of Mss51-style regulation not established
• Recruitment order and binding interfaces among COA3, COX14, CMC1 and COX1 unknown